Expression of Rasd1 in mouse endocrine pituitary cells and its response to dexamethasone

Chad D Foradori1, Laci Mackay1, Chen-Che J Huang1

  • 1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.

Insights

Dexamethasone-induced Ras-related protein 1 (Rasd1) is highly expressed in pituitary corticotrophs and increases with dexamethasone (Dex) treatment, supporting its role in glucocorticoid feedback. Rasd1 is also found in other pituitary cells, suggesting new functions.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Dexamethasone-induced Ras-related protein 1 (Rasd1) is a Ras superfamily G protein involved in signal transduction.
  • Rasd1 is rapidly induced by dexamethasone (Dex) and highly expressed in the pituitary, potentially regulating corticotroph activity.
  • The precise cellular localization and cell-type-specific response to Dex-induced Rasd1 expression in the pituitary remain unclear.

Purpose of the Study:

  • To investigate the cellular localization of Rasd1 in different pituitary cell types.
  • To determine which pituitary endocrine cell types are responsive to Dex-induced Rasd1 expression.
  • To examine the role of Rasd1 in glucocorticoid negative feedback and explore potential novel pituitary functions.

Main Methods:

  • Adult male mice were used to examine Rasd1 expression in pituitary cell types.
  • Immunohistochemistry was employed to detect Rasd1 expression under basal conditions and 1-hour post-dexamethasone (Dex) or vehicle treatment.
  • Quantitative analysis of Rasd1 expression in corticotrophs, thyrotrophs, lactotrophs, somatotrophs, and gonadotrophs was performed.

Main Results:

  • Under basal conditions, a majority of corticotrophs and thyrotrophs expressed Rasd1 (50-60%), with lower expression in lactotrophs, somatotrophs, and gonadotrophs (15-30%).
  • Dexamethasone (Dex) treatment significantly increased Rasd1 expression in corticotrophs (80-95%), somatotrophs, lactotrophs, and gonadotrophs, but not thyrotrophs.
  • Corticotrophs in the pars intermedia, lacking glucocorticoid receptors, did not show increased Rasd1 expression after Dex treatment.

Conclusions:

  • Rasd1 is highly expressed in pituitary corticotrophs and its expression is upregulated by dexamethasone (Dex), supporting its role in glucocorticoid negative feedback.
  • The presence and Dex-induced expression of Rasd1 in multiple pituitary cell types suggest potential novel functions beyond glucocorticoid regulation.
  • Further research is warranted to elucidate the specific roles of Rasd1 in various pituitary endocrine cell types.